Literature DB >> 15983143

Apnea during induction of anesthesia with sevoflurane is related to its mode of administration.

Carlo Pancaro1, Simone Giovannoni, Adelchi Toscano, Vito Aldo Peduto.   

Abstract

PURPOSE: The incidence and duration of apnea during sevoflurane anesthesia have not been fully characterized. We hypothesized that sevoflurane at slowly increasing concentrations reduces incidence and shortens the duration of apnea compared to administration of a highly concentrated anesthetic mixture.
METHODS: 131 women were randomly assigned to receive 35% oxygen in air and sevoflurane at: incremental concentrations of 1%, from 1% to 8% (group 1-8%, n = 42); decremental-incremental concentrations of 2%, from 8% to 4% and then from 4% to 8% (group 8-4-8%, n = 36); or fixed concentrations of 8% for induction of anesthesia (group 8%, n = 53). A blinded investigator observed whether and for how long patients stopped breathing.
RESULTS: All groups reached 2.5 minimum alveolar concentration of end-tidal sevoflurane. Although apnea was observed in all groups, it was more frequent in the 8% group than in 1 to 8% (68% vs 21%, P < 0.05) or 8 to 4 to 8% groups (68% vs 20%, P < 0.05). Duration of apnea was also more pronounced in the 8% group than in 1 to 8% and 8 to 4 to 8% groups ( 58 +/- 25 s vs 32 +/- 18 sec, P < 0.05 and vs 35 +/- 16 sec, P < 0.05, respectively).
CONCLUSIONS: Sevoflurane induces apnea more frequently and for longer duration at a fixed high concentration compared to incremental or decremental-incremental concentrations. Decremental-incremental concentrations offer the additional advantage of a speed of induction similar to that elicited by the 8% concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983143     DOI: 10.1007/BF03015767

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  5 in total

Review 1.  High initial concentration versus low initial concentration sevoflurane for inhalational induction of anaesthesia.

Authors:  Polpun Boonmak; Suhattaya Boonmak; Porjai Pattanittum
Journal:  Cochrane Database Syst Rev       Date:  2016-06-29

2.  The optimum sevoflurane concentration for supraglottic airway device Blockbuster™ insertion with spontaneous breathing in obese patients: a prospective observational study.

Authors:  Haixia Wang; Xue Gao; Wei Wei; Huihui Miao; Hua Meng; Ming Tian
Journal:  BMC Anesthesiol       Date:  2017-11-28       Impact factor: 2.217

3.  A Co-Induction Technique Utilizing 4% Sevoflurane Followed by 0.75 mg/kg Propofol in Elderly Patients Undergoing Minimally Invasive Procedures: A Prospective Randomized Control Study.

Authors:  Omar A Ababneh; Aiman M Suleiman; Isam K Bsisu; Subhi M Al-Ghanem; Walid K Samarah; Khaled R Al-Zaben; Ibraheem Y Qudaisat; Lubna A Khreesha; Ghazi M Al Edwan; Mujalli M Murshidi
Journal:  Medicina (Kaunas)       Date:  2020-12-10       Impact factor: 2.430

4.  Propofol/Fentanyl/Rocuronium or Sevoflurane Inhalational Induction for Intubation?

Authors:  Giakoumis Mitos; Giannoula Thoma; Georgia Tsaousi
Journal:  Cureus       Date:  2021-11-12

5.  Optimum end-tidal concentration of sevoflurane to facilitate supraglottic airway device insertion with propofol at induction allowing spontaneous respiration in obese patients: A prospective observational study.

Authors:  Hai-Xia Wang; Hui-Hui Miao; Xue Gao; Wei Wei; Guan-Nan Ding; Ye Zhang; Ming Tian
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.